Full Press Release Details
MINNEAPOLIS , May 31, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH ) today announced that Kim Kelderman , President and Chief Executive Officer will present at the following investor conferences:
William Blair 44 th Annual Growth Conference June 4, 2024 9:20 AM CDT
Jefferies Global Healthcare Conference June 6, 2024 9:30 AM EDT
Goldman Sachs 45 th Annual Global Healthcare Conference June 11, 2024 9:20 AM EDT
A live webcast of the presentations can be accessed via the IR Calendar page of Bio-Techne's Investor Relations website at https://investors.bio-techne.com/ir-calendar .
About Bio-Techne Bio-Techne Corporation (NASDAQ: TECH ) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With thousands of products in its portfolio, Bio-Techne generated over $1.1 billion in net sales in fiscal 2023 and has approximately 3,100 employees worldwide. For more information on Bio-Techne and its brands, please visit https://www.bio-techne.com or follow the Company on social media at: Facebook , LinkedIn , Twitter or YouTube .
| Contact: | David Clair, Vice President, Investor Relations & Corporate Development |
| [email protected] | |
| 612-656-4416 |
SOURCE Bio-Techne Corporation